Little House Capital LLC Vertex Pharmaceuticals Inc Transaction History

Little House Capital LLC

$346 Million
Q1 2025

A detailed history of Little House Capital LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Little House Capital LLC holds 6,307 shares of VRTX stock, worth $2.78 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares

6,307

Previous 4,734 33.23%

Holding current value

$2.78 Million

Previous $1.91 Million 60.39%

% of portfolio

0.88%

Previous 0.55%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	BUY	$402.49 - $513.76 $633,116 - $808,144	1,573 Added 33.23%	6,307 $3.06 Million
Q4 2024 Jan 30, 2025	BUY	$396.64 - $516.74 $401,003 - $522,424	1,011 Added 27.16%	4,734 $1.91 Million
Q3 2024 Oct 21, 2024	BUY	$460.0 - $505.78 $475,180 - $522,470	1,033 Added 38.4%	3,723 $1.73 Million
Q2 2024 Aug 01, 2024	BUY	$392.81 - $485.53 $75,026 - $92,736	191 Added 7.64%	2,690 $1.26 Million
Q1 2024 Apr 18, 2024	BUY	$407.69 - $446.08 $72,976 - $79,848	179 Added 7.72%	2,499 $1.04 Million
Q4 2023 Feb 05, 2024	BUY	$343.0 - $410.68 $294,637 - $352,774	859 Added 58.8%	2,320 $943,000
Q3 2023 Oct 30, 2023	BUY	$338.18 - $362.46 $14,203 - $15,223	42 Added 2.96%	1,461 $508,000
Q2 2023 Jul 18, 2023	BUY	$314.42 - $351.91 $4,401 - $4,926	14 Added 1.0%	1,419 $499,000
Q1 2023 May 04, 2023	BUY	$283.23 - $323.1 $3,398 - $3,877	12 Added 0.86%	1,405 $442,000
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $4,000 - $4,500	-14 Reduced 1.0%	1,393 $402,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $6,298 - $7,027	23 Added 1.66%	1,407 $407,000
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $77,771 - $96,834	-331 Reduced 19.3%	1,384 $390,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $23,913 - $28,184	108 Added 6.72%	1,715 $448,000
Q4 2021 Feb 15, 2022	BUY	$177.01 - $223.45 $51,686 - $65,247	292 Added 22.21%	1,607 $353,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $238,527 - $266,931	1,315 New	1,315 $239,000
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $289,620 - $337,592	-1,399 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $289,606 - $386,249	1,399 New	1,399 $330,000

Others Institutions Holding VRTX

# of Institutions

1,834

Shares Held

233M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $113B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Little House Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Little House Capital LLC with notifications on news.

Account

Little House Capital LLC Vertex Pharmaceuticals Inc Transaction History